Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
(NY:
FOXO
)
0.1337
-0.0063 (-4.50%)
Streaming Delayed Price
Updated: 3:16 PM EDT, Aug 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about FOXO
< Previous
1
2
Next >
FOXO Technologies Announces Appointment of Capital Markets Veteran Francis Colt deWolf to the Board of Directors
January 25, 2024
From
FOXO Technologies Inc.
Via
Business Wire
FOXO Technologies Formalizes License Agreement with KR8.ai to Power New Epigenetic Wellness Solutions
January 22, 2024
From
FOXO Technologies Inc.
Via
Business Wire
FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements
December 19, 2023
From
FOXO Technologies Inc.
Via
Business Wire
FOXO Technologies On Track to Commence Commercial Rollout of VITHAR™ AI Health Coach in Early 2024
December 01, 2023
From
FOXO Technologies Inc.
Via
Business Wire
FOXO Technologies Receives Notice from NYSE American Regarding Late Filing of Quarterly Report on Form 10-Q
November 29, 2023
From
FOXO Technologies Inc.
Via
Business Wire
FOXO Technologies Provides Reminder for Webinar to be Held Today, November 10th at 10 AM Eastern Time, to Unveil VITHAR™ AI Health Coach
November 10, 2023
From
FOXO Technologies Inc.
Via
Business Wire
FOXO Technologies to Unveil VITHAR™ AI Health Coach; Schedules Webinar for Friday, November 10th at 10 AM Eastern Time
November 08, 2023
From
FOXO Technologies Inc.
Via
Business Wire
FOXO Technologies Expects Class A Common Stock to Resume Trading, Today, November 7, in Connection with 1-for-10 Reverse Stock Split
November 07, 2023
From
FOXO Technologies Inc.
Via
Business Wire
FOXO Technologies Unveils Plans for New Direct-to Consumer Offering Combining the Company’s Epigenetic Data with the Power of AI
October 30, 2023
From
FOXO Technologies Inc.
Via
Business Wire
FOXO Technologies Inc. Announces Reverse Stock Split
October 27, 2023
From
FOXO Technologies Inc.
Via
Business Wire
FOXO Technologies Completes Strategic Alternatives Review and Outlines Latest Progress Executing Corporate Strategy
October 23, 2023
From
FOXO Technologies Inc.
Via
Business Wire
FOXO Technologies Announces Issue Notification from USPTO for a Patent Leveraging Machine Learning Approaches to Enable the Commercialization of Epigenetic Biomarkers
October 13, 2023
From
FOXO Technologies Inc.
Via
Business Wire
FOXO Technologies™ Interim CEO Mark White Provides Letter to Shareholders Outlining New AI-Enabled Direct-to-Consumer Strategy and Immediate Expense Reductions
October 06, 2023
From
FOXO Technologies Inc.
Via
Business Wire
FOXO Technologies Announces Agreement With Atrio Insurance
September 06, 2023
From
FOXO Technologies Inc.
Via
Business Wire
FOXO Technologies Inc. Announces NYSE American Acceptance of Compliance Plan
August 31, 2023
From
FOXO Technologies Inc.
Via
Business Wire
FOXO Technologies Inc. Announces Receipt of Second Notice of Non-Compliance from NYSE American
August 18, 2023
From
FOXO Technologies Inc.
Via
Business Wire
FOXO Technologies™ Collaborates with DataRobot to Pave the Way for AI-Driven Epigenetic Biomarker Research in Human Longevity
August 17, 2023
From
FOXO Technologies
Via
Business Wire
FOXO Technologies™ Announces Second Quarter 2023 Financial Results
August 10, 2023
From
FOXO Technologies Inc.
Via
Business Wire
FOXO Technologies™ Sets Second Quarter 2023 Business Update Call for Thursday, August 10, 2023 at 3:15 p.m. CT
August 08, 2023
From
FOXO Technologies Inc.
Via
Business Wire
Longevity Biotech Companies GERO and FOXO Technologies™ to Embark on Joint Initiative on Artificial Intelligence and Epigenetic Data to Discover Signatures of Human Health Trajectories
August 07, 2023
From
FOXO Technologies Inc.
Via
Business Wire
FOXO Technologies Launches Bioinformatics Services to Revolutionize Epigenetic Data Analysis
July 19, 2023
From
FOXO Technologies Inc.
Via
Business Wire
FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements
June 16, 2023
From
FOXO Technologies Inc.
Via
Business Wire
FOXO Technologies Announces Results of Annual Stockholders Meeting
May 30, 2023
From
FOXO Technologies Inc.
Via
Business Wire
NYSE American Has Commenced Delisting Proceedings in the FOXO WS warrants of FOXO Technologies Inc.
May 17, 2023
From
FOXO Technologies Inc.
Via
Business Wire
FOXO Technologies™ Announces First Quarter 2023 Financial Results
May 11, 2023
From
FOXO Technologies Inc.
Via
Business Wire
FOXO Technologies™ Announces Resignation of Taylor Fay, Chief Operating Officer
April 18, 2023
From
FOXO Technologies Inc.
Via
Business Wire
FOXO Technologies Announces Direct-to-Consumer Launch of Longevity Report Beta Product
April 18, 2023
From
FOXO Technologies Inc.
Via
Business Wire
FOXO Technologies Inc. (FOXO) Class Acton Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against FOXO Technologies Inc.
April 17, 2023
From
Robbins LLP
Via
Business Wire
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against FOXO Technologies Inc. (FOXO)
March 31, 2023
From
Robbins LLP
Via
Business Wire
FOXO Technologies™ Announces Full Year 2022 Financial Results and Recent Business Highlights
March 30, 2023
From
FOXO Technologies Inc.
Via
Business Wire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.